| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | -0.00052 | 1 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.00047 | 1 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | -0.00062 | 1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | -0.00041 | 1 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.0004 | 1 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.00032 | 1 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.00024 | 1 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.00022 | 1 |
| mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.00018 | 1 |
| mRNA | SJ-172550 | CTRPv2 | pan-cancer | AAC | 9.8e-05 | 1 |